Schedule 13G ownership disclosure
COGENT BIOSCIENCES INC
Common Stock · CUSIP: 19240Q201
Event date: 2025-07-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deerfield Mgmt, L.P.
Shares: 9,053,118.00 · Class: 6.49%
- Deerfield Management Company, L.P.
Shares: 9,053,118.00 · Class: 6.49%
- Deerfield Partners, L.P.
Shares: 9,053,118.00 · Class: 6.49%
- James E. Flynn
Shares: 9,053,118.00 · Class: 6.49%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-001001
- Form type
- SCHEDULE 13G
- Filer
- Cogent Biosciences, Inc.
- CIK
- CIK 1622229
- Filed
- Jul 11, 2025
- Reporting period
- Jul 07, 2025
- Description
- Schedule 13G beneficial ownership